Skip to main content

Peer Review reports

From: ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition

Original Submission
6 Dec 2020 Submitted Original manuscript
15 Mar 2021 Reviewed Reviewer Report
16 Mar 2021 Reviewed Reviewer Report
5 Apr 2021 Author responded Author comments - Jun Jia
Resubmission - Version 2
5 Apr 2021 Submitted Manuscript version 2
14 Apr 2021 Author responded Author comments - Jun Jia
Resubmission - Version 3
14 Apr 2021 Submitted Manuscript version 3
16 Apr 2021 Author responded Author comments - Jun Jia
Resubmission - Version 4
16 Apr 2021 Submitted Manuscript version 4
16 Apr 2021 Author responded Author comments - Jun Jia
Resubmission - Version 5
16 Apr 2021 Submitted Manuscript version 5
26 Apr 2021 Reviewed Reviewer Report
10 May 2021 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
11 May 2021 Editorially accepted
15 May 2021 Article published 10.1186/s12890-021-01540-4

You can find further information about peer review here.

Back to article page